Evidence map›Paper›PMID 33422019›Full record

Trial reportBMC medical research methodology2021

Missing not at random in end of life care studies: multiple imputation and sensitivity analysis on data from the ACTION study.

Giulia Carreras, Guido Miccinesi, Andrew Wilcock, Nancy Preston, Daan Nieboer, Luc Deliens, Mogensm Groenvold, Urska Lunder, Agnes van der Heide, Michela Baccini and 1 more

Registry-linked trialAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in BMC medical research methodology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05318612 (), which is not on this map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05318612 phase3active not recruitingnot on this mapstarted 2022, after this paper: background citation

(Cost)Effectiveness of MR-guided LITT Therapy in Patients With Primary Irresectable Glioblastoma: a Prospective Multicenter Randomized Controlled Trial (EMITT)

TypeinterventionalSponsorRadboud University Medical CenterRan2022 to 2027Enrolled238ConditionsPrimary GlioblastomaArmsLaser Interstitial Thermal Therapy (LITT), Biopsy
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Relationship between reasons for intermittent missing patient-reported outcomes data and missing data mechanisms.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2024
    Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Giulia CarrerasOncological Network, Prevention and Research Institute (ISPRO), Florence, Italy. g.carreras@ispro.toscana.it.ORCID 0000-0002-1427-637X
Guido MiccinesiOncological Network, Prevention and Research Institute (ISPRO), Florence, Italy.
Andrew WilcockDepartment of Clinical Oncology, University of Nottingham, Nottingham, UK.
Nancy PrestonLancaster University, International Observatory on end of life care, Lancaster, UK.
Daan NieboerDepartment of Public Health, Erasmus University, Rotterdam, Netherlands.
Luc DeliensVrije Universiteit Brussel & Ghent University, Brussels, Belgium.
Mogensm GroenvoldDepartment of Public Health, Copenhagen University, Copenhagen, Denmark.
Urska LunderUniversity Clinic for Respiratory and Allergic Diseases, Golnik, Slovenia.
Agnes van der HeideDepartment of Public Health, Erasmus University, Rotterdam, Netherlands.
Michela BacciniDepartment of Statistics, Computer Science, Applications 'G. Parenti' (DISIA), University of Florence, Florence, Italy.
ACTION consortium

Funding

Seventh Framework Programme () 602541-2
6 · The paper itself

Abstract

backgroundMissing data are common in end-of-life care studies, but there is still relatively little exploration of which is the best method to deal with them, and, in particular, if the missing at random (MAR) assumption is valid or missing not at random (MNAR) mechanisms should be assumed. In this paper we investigated this issue through a sensitivity analysis within the ACTION study, a multicenter cluster randomized controlled trial testing advance care planning in patients with advanced lung or colorectal cancer.

methodsMultiple imputation procedures under MAR and MNAR assumptions were implemented. Possible violation of the MAR assumption was addressed with reference to variables measuring quality of life and symptoms. The MNAR model assumed that patients with worse health were more likely to have missing questionnaires, making a distinction between single missing items, which were assumed to satisfy the MAR assumption, and missing values due to completely missing questionnaire for which a MNAR mechanism was hypothesized. We explored the sensitivity to possible departures from MAR on gender differences between key indicators and on simple correlations.

resultsUp to 39% of follow-up data were missing. Results under MAR reflected that missingness was related to poorer health status. Correlations between variables, although very small, changed according to the imputation method, as well as the differences in scores by gender, indicating a certain sensitivity of the results to the violation of the MAR assumption.

conclusionsThe findings confirmed the importance of undertaking this kind of analysis in end-of-life care studies.

Indexed as

Quality of LifeTerminal CareHumansModels, StatisticalResearch DesignAdvance care planningMARMissing dataMNAROncologyQuality of life

Identifiers

PMID33422019
PMCPMC7796568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.